• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肾周原发性脂肪肉瘤靠近肾脏行根治性肾切除术对无病生存率有益。

Radical Nephrectomy for Primary Retroperitoneal Liposarcoma Near the Kidney has a Beneficial Effect on Disease-Free Survival.

机构信息

Department of Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, 50 Irwon-dong, Gangnam-gu, Seoul, 135-710, Korea.

Department of Pathology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.

出版信息

World J Surg. 2018 Jan;42(1):254-262. doi: 10.1007/s00268-017-4157-6.

DOI:10.1007/s00268-017-4157-6
PMID:28808758
Abstract

BACKGROUND

The purpose of this study is to analyze the clinical impact of radical nephrectomy on retroperitoneal liposarcoma near the kidney.

METHODS

Data of patients who underwent surgery for unilateral primary retroperitoneal liposarcoma near the kidney were retrospectively collected. Patients were divided into four groups according to whether they underwent nephrectomy and combined resection of other organs. Kaplan-Meier survival analysis was used to estimate disease-free survival and overall survival. Multivariable Cox analysis was used to analyze factors related to disease-free survival and overall survival.

RESULTS

Nephrectomy (HR = 0.260, CI = 0.078-0.873, p = 0.029) had a beneficial effect on disease-free survival, while interaction model of nephrectomy*other organ resection (HR = 4.655, CI = 1.767-12.263, p = 0.002) showed poor disease-free survival. Other organ resection was not related to disease-free survival (HR = 1.543, CI = 0.146-16.251, p = 0.718). Operation method (p = 0.007) and FNCLCC grade (p < 0.001; G2, HR = 1.833, CI = 0.684-4.915, p = 0.228; G3, HR = 9.190, CI = 3.351-25.199, p < 0.001) were significant factors for disease-free survival. While combined organ resection without nephrectomy group (HR = 1.604, CI = 0.167-15.370, p = 0.682) and radical nephrectomy with combined organ resection group (HR = 1.309, CI = 0.448-3.825, p = 0.622) did not show significant difference in disease-free survival from the mass excision only group, radical nephrectomy without combined organ resection group (HR = 0.279, CI = 0.078-0.991, p = 0.048) showed superior disease-free survival.

CONCLUSIONS

Radical nephrectomy of unilateral primary retroperitoneal liposarcoma near the kidney has a beneficial effect on disease-free survival.

摘要

背景

本研究旨在分析肾周邻近部位脂肪肉瘤根治性肾切除术的临床影响。

方法

回顾性收集单侧原发性肾周邻近部位脂肪肉瘤患者的手术资料。根据是否行肾切除术及合并其他器官切除将患者分为四组。采用 Kaplan-Meier 生存分析估计无病生存率和总生存率。采用多变量 Cox 分析分析无病生存率和总生存率的相关因素。

结果

肾切除术(HR=0.260,CI=0.078-0.873,p=0.029)对无病生存率有益,而肾切除术*其他器官切除术的交互模型(HR=4.655,CI=1.767-12.263,p=0.002)显示无病生存率较差。其他器官切除术与无病生存率无关(HR=1.543,CI=0.146-16.251,p=0.718)。手术方式(p=0.007)和 FNCLCC 分级(p<0.001;G2,HR=1.833,CI=0.684-4.915,p=0.228;G3,HR=9.190,CI=3.351-25.199,p<0.001)是无病生存率的显著因素。而无肾切除术联合器官切除组(HR=1.604,CI=0.167-15.370,p=0.682)和根治性肾切除术联合器官切除组(HR=1.309,CI=0.448-3.825,p=0.622)与单纯肿块切除术组无病生存率无显著差异,根治性肾切除术无联合器官切除组(HR=0.279,CI=0.078-0.991,p=0.048)无病生存率较高。

结论

单侧原发性肾周邻近部位脂肪肉瘤根治性肾切除术对无病生存率有益。

相似文献

1
Radical Nephrectomy for Primary Retroperitoneal Liposarcoma Near the Kidney has a Beneficial Effect on Disease-Free Survival.肾周原发性脂肪肉瘤靠近肾脏行根治性肾切除术对无病生存率有益。
World J Surg. 2018 Jan;42(1):254-262. doi: 10.1007/s00268-017-4157-6.
2
Histologic subtype and margin of resection predict pattern of recurrence and survival for retroperitoneal liposarcoma.组织学亚型和手术切缘可预测腹膜后脂肪肉瘤的复发模式和生存率。
Ann Surg. 2003 Sep;238(3):358-70; discussion 370-1. doi: 10.1097/01.sla.0000086542.11899.38.
3
[Differentiated surgical approach for retroperitoneal non-organ liposarcoma].[腹膜后非器官性脂肪肉瘤的差异化手术方法]
Khirurgiia (Mosk). 2021(7):36-44. doi: 10.17116/hirurgia202107136.
4
Single-center experience with intra-abdominal liposarcoma: Optimal minimum duration for postoperative remnant tumor screening.腹腔脂肪肉瘤的单中心经验:术后残余肿瘤筛查的最佳最短持续时间
Medicine (Baltimore). 2017 Aug;96(33):e7537. doi: 10.1097/MD.0000000000007537.
5
Optimal maximum duration for delaying salvage operation when recurrence of retroperitoneal liposarcoma is suspected: a single-center study.怀疑腹膜后脂肪肉瘤复发时,延迟挽救性手术的最佳最长持续时间:一项单中心研究。
Int J Clin Oncol. 2019 May;24(5):583-589. doi: 10.1007/s10147-018-01383-w. Epub 2019 Jan 2.
6
Short- and long-term post-nephrectomy outcomes for retroperitoneal liposarcoma from a high-volume sarcoma center: a propensity score matching analysis.来自高容量肉瘤中心的腹膜后脂肪肉瘤的肾切除术后短期和长期结果:倾向评分匹配分析。
Int J Clin Oncol. 2024 Jul;29(7):1035-1043. doi: 10.1007/s10147-024-02530-2. Epub 2024 Apr 23.
7
Myogenic differentiation and histologic grading are major prognostic determinants in retroperitoneal liposarcoma.肌源性分化和组织学分级是腹膜后脂肪肉瘤主要的预后决定因素。
Am J Surg Pathol. 2015 Mar;39(3):383-93. doi: 10.1097/PAS.0000000000000366.
8
Clinical features and surgical strategy of retroperitoneal liposarcoma involving the kidney capsule: a retrospective comparative cohort study.腹膜后脂肪肉瘤累及肾被膜的临床特征和手术策略:一项回顾性对比队列研究。
Int J Surg. 2024 Sep 1;110(9):5355-5362. doi: 10.1097/JS9.0000000000001774.
9
[Combined operations by retroperitoneal liposarcomas].[腹膜后脂肪肉瘤的联合手术]
Khirurgiia (Mosk). 2013(6):20-5.
10
Predicting outcome by growth rate of locally recurrent retroperitoneal liposarcoma: the one centimeter per month rule.预测局部复发性腹膜后脂肪肉瘤生长速度的预后:每月 1 厘米法则。
Ann Surg. 2009 Dec;250(6):977-82. doi: 10.1097/sla.0b013e3181b2468b.

引用本文的文献

1
Surgical management of giant retroperitoneal liposarcoma: Case report.巨大腹膜后脂肪肉瘤的外科治疗:病例报告
Rare Tumors. 2024 Jul 24;16:20363613241266047. doi: 10.1177/20363613241266047. eCollection 2024.
2
Predictors and outcomes of recurrent retroperitoneal liposarcoma with multiple tumors.伴有多个肿瘤的复发性腹膜后脂肪肉瘤的预测因素及预后
Front Med (Lausanne). 2023 Sep 8;10:1161494. doi: 10.3389/fmed.2023.1161494. eCollection 2023.
3
Bilateral Renal Auto-Transplantation for Retroperitoneal Sarcomas: Is It Underutilized?

本文引用的文献

1
Multivisceral resection of retroperitoneal sarcomas in the elderly.老年患者腹膜后肉瘤的多脏器切除术
Eur J Cancer. 2016 Dec;69:119-126. doi: 10.1016/j.ejca.2016.09.037. Epub 2016 Nov 4.
2
Oncovascular compartmental resection for retroperitoneal soft tissue sarcoma with vascular involvement.伴有血管受累的腹膜后软组织肉瘤的肿瘤血管分区切除术
J Vasc Surg. 2016 Oct;64(4):1033-41. doi: 10.1016/j.jvs.2016.04.006. Epub 2016 Jun 30.
3
The effect of microscopic margin status on survival in adult retroperitoneal soft tissue sarcomas.
双侧肾自体移植治疗腹膜后肉瘤:是否未得到充分利用?
Curr Oncol. 2023 Aug 14;30(8):7620-7626. doi: 10.3390/curroncol30080552.
4
Postoperative Outcomes of Distal Pancreatectomy for Retroperitoneal Sarcoma Abutting the Pancreas in the Left Upper Quadrant.左上腹毗邻胰腺的腹膜后肉瘤行胰体尾切除术的术后结果
Front Oncol. 2021 Dec 20;11:792943. doi: 10.3389/fonc.2021.792943. eCollection 2021.
5
Maximum standardized uptake value on F-fluorodeoxyglucose positron emission tomography/computed tomography improves outcome prediction in retroperitoneal liposarcoma.F-氟代脱氧葡萄糖正电子发射断层扫描/计算机断层扫描的最大标准化摄取值可改善腹膜后脂肪肉瘤的预后预测。
Sci Rep. 2019 Apr 29;9(1):6605. doi: 10.1038/s41598-019-43215-5.
6
Dedifferentiated retroperitoneal large liposarcoma and laparoscopic treatment: Is it possible and safe? The first literature case report.去分化型腹膜后大脂肪肉瘤与腹腔镜治疗:可行且安全吗?首例文献病例报告。
Int J Surg Case Rep. 2019;57:113-117. doi: 10.1016/j.ijscr.2019.03.023. Epub 2019 Mar 26.
7
Retroperitoneal dedifferentiated liposarcoma.腹膜后去分化脂肪肉瘤
Intern Emerg Med. 2019 Jun;14(4):619-620. doi: 10.1007/s11739-018-2004-x. Epub 2018 Dec 5.
8
Anterior Approach to En Bloc Resection in Left-Sided Retroperitoneal Sarcoma with Adjacent Organ Involvement: A Study of 25 Patients in a Single Center.左侧腹膜后肉瘤伴毗邻器官侵犯整块切除术的前入路:单中心 25 例患者研究。
Med Sci Monit. 2018 Feb 16;24:961-969. doi: 10.12659/msm.908559.
9
Hibernation of masses suspected to be remnant tumors after surgical resection of retroperitoneal liposarcoma is related to improved overall survival.腹膜后脂肪肉瘤切除术后疑似残余肿瘤的休眠与总体生存改善有关。
Int J Clin Oncol. 2018 Aug;23(4):765-774. doi: 10.1007/s10147-018-1243-1. Epub 2018 Jan 19.
显微镜下切缘状态对成人腹膜后软组织肉瘤生存的影响。
Eur J Surg Oncol. 2017 Jan;43(1):168-174. doi: 10.1016/j.ejso.2016.05.031. Epub 2016 Jun 10.
4
Long-term outcomes in treatment of retroperitoneal sarcomas: A 15 year single-institution evaluation of prognostic features.腹膜后肉瘤治疗的长期结果:一项针对预后特征的15年单机构评估
J Surg Oncol. 2016 Jul;114(1):56-64. doi: 10.1002/jso.24256. Epub 2016 Apr 13.
5
Surgical Management of Retroperitoneal Soft Tissue Sarcomas: Role of Curative Resection.腹膜后软组织肉瘤的外科治疗:根治性切除的作用
Am Surg. 2016 Feb;82(2):128-33.
6
Retroperitoneal sarcomas: patterns of care in advanced stages, prognostic factors and focus on main histological subtypes: a multicenter analysis of the French Sarcoma Group.腹膜后肉瘤:晚期的治疗模式、预后因素及主要组织学亚型分析:法国肉瘤研究组的多中心分析
Ann Oncol. 2014 Mar;25(3):730-734. doi: 10.1093/annonc/mdt576. Epub 2014 Feb 3.
7
Outcome prediction in primary resected retroperitoneal soft tissue sarcoma: histology-specific overall survival and disease-free survival nomograms built on major sarcoma center data sets.原发性切除的腹膜后软组织肉瘤的预后预测:基于大型肉瘤中心数据集的组织学特异性总生存和无病生存列线图。
J Clin Oncol. 2013 May 1;31(13):1649-55. doi: 10.1200/JCO.2012.44.3747. Epub 2013 Mar 25.
8
Surgical management of primary retroperitoneal sarcoma.原发性腹膜后肉瘤的外科治疗。
Br J Surg. 2010 May;97(5):698-706. doi: 10.1002/bjs.6994.
9
Liposarcoma: exploration of clinical prognostic factors for risk based stratification of therapy.脂肪肉瘤:基于风险的治疗分层临床预后因素探索
BMC Cancer. 2009 Jun 26;9:205. doi: 10.1186/1471-2407-9-205.
10
Primary and locally recurrent retroperitoneal soft-tissue sarcoma: local control and survival.原发性及局部复发性腹膜后软组织肉瘤:局部控制与生存情况
Eur J Surg Oncol. 2009 Sep;35(9):986-93. doi: 10.1016/j.ejso.2008.11.003. Epub 2009 Jan 12.